International Urology and Nephrology

, Volume 42, Issue 1, pp 127–131 | Cite as

Metabolic abnormalities in patients with nephrolithiasis: comparison of first-episode with recurrent cases in Southern Iran

  • Mohammad Mehdi Hosseini
  • Ahad EshraghianEmail author
  • Ilnaz Dehghanian
  • Dariush Irani
  • Mitra Amini
Urology - Original Paper



Metabolic disorders are one of the etiologic factors in renal stone formation. The aim of present study was to evaluate prevalence of metabolic disorders in patients with renal stone.


From 572 patients referring to our urologic clinics, 376 patients participated in the study. Patients were divided to first time stone former (group A) and recurrent renal stone (group B). Twenty-four hour urine specimens were obtained for urinary calcium, oxalate, magnesium, citrate, uric acid, phosphor and 24-h urine volume. Venous blood samples were obtained evaluating serum phosphate, uric acid, and calcium. The prevalence of each metabolic disorder was detected, and two groups were compared regarding metabolic disorders.


The prevalence of renal stone in male patients was 63.04% versus 36.96% in female patients (P < 0.05). The most common abnormality observed in patients was low 24-h urine volume (58.24%) followed by hypercalciuria (17.18%) and hyperuricosuria (15.15%). Hyperuricemia was found in 6 first time stone former patients and 14 patients with recurrent renal stone (P = 0.04). There was no statistically significant difference between group A and B in other metabolic abnormalities (P > 0.05).


Low 24-h urine volume was the most common abnormalities in patients with nephrolithiasis in our region. Metabolic evaluation must be performed in all patients with renal stone even those with first time stone formation.


Metabolic abnormalities Renal stone First time stone former Recurrent renal stone 


  1. 1.
    Moe OW (2006) Kidney stones: pathophysiology and medical management. Lancet 367:333–344CrossRefPubMedGoogle Scholar
  2. 2.
    Pak CYC, Resnick MI, Preminger GM (1997) Ethnic and geographic diversity of stone disease. Urology 50:504–507CrossRefPubMedGoogle Scholar
  3. 3.
    Evan AP, Bledsoe SB, Smith SB, Bushinsky DA (2004) Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats. Kidney Int 65:154–161CrossRefPubMedGoogle Scholar
  4. 4.
    Schor Ita Pfeferman Heilberg Nestor (2006) Renal stone disease: causes, evaluation and medical treatment. Arq Bras Endocrinol Metab 50:823–831Google Scholar
  5. 5.
    Bushinsky DA (1998) Nephrolithiasis. J Am Soc Nephrol 9:917–924PubMedGoogle Scholar
  6. 6.
    Coe FL, Parks JH, Asplin JR (1992) The pathogenesis and treatment of kidney stones. N Engl J Med 327:1141–1152PubMedGoogle Scholar
  7. 7.
    Coe FL, Parks JH (1997) New insights into the pathophysiology and treatment of nephrolithiasis: new research venues. J Bone Miner Res 12:522–533CrossRefPubMedGoogle Scholar
  8. 8.
    Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A (1996) Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155:839–843CrossRefPubMedGoogle Scholar
  9. 9.
    Coe FL, Parks JH (1998) Nephrolithiasis: pathogenesis and treatment, 2nd edn. Year Book Medical Publishers, Chicago, pp 109–110Google Scholar
  10. 10.
    Albright F, Henneman P, Benedict PH, Forbes AP (1953) Idiopathic hypercalciuria: a preliminary report. Proc Roy Soc Med 46:1077–1081PubMedGoogle Scholar
  11. 11.
    Yagisawa T, Chandhoke PS, Fan J (1998) Metabolic risk factors in patients with first-time and recurrent stone formations as determined by comprehensive metabolic evaluation. Urology 52:750–755CrossRefPubMedGoogle Scholar
  12. 12.
    Leslie SW (1989) Outpatient metabolic evaluation of patients with recurrent kidney stones. Ohio Med 85:292–294PubMedGoogle Scholar
  13. 13.
    Auge BK, Maloney ME, Mathias BJ, Pietrow PK, Preminger GM (2006) Metabolic abnormalities associated with calyceal diverticular stones. BJU Int 97:1053–1056CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, B.V. 2009

Authors and Affiliations

  • Mohammad Mehdi Hosseini
    • 1
  • Ahad Eshraghian
    • 1
    Email author
  • Ilnaz Dehghanian
    • 1
  • Dariush Irani
    • 1
  • Mitra Amini
    • 2
  1. 1.Endourology Ward, Urology Department, Nephrology-Urology Research CenterShiraz University of Medical ScienceShirazIran
  2. 2.Education Development CenterShiraz University of Medical ScienceShirazIran

Personalised recommendations